Nathan Weinstein
Stock Analyst at Aegis Capital
(0.28)
# 4,387
Out of 5,182 analysts
59
Total ratings
13.79%
Success rate
-24.81%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $0.81 | +9,776.54% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $400 → $300 | $7.46 | +3,921.45% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.16 | +3,576.47% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $0.96 | +3,564.92% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $1.97 | +204.57% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $3.83 | +683.29% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $15.40 | -35.06% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $17.35 | +182.42% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $63,000 → $1,800 | $3.65 | +49,215.07% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $6.03 | +35,720.90% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.69 | +7,000.59% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.59 | +1,604.16% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $40.07 | +39.76% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $4.90 | +451.02% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $1.07 | +3,171.03% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.34 | +795.52% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $24.52 | +205.87% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $2.18 | +3,936.70% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.61 | +29,471.22% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $11.30 | +1,095.22% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $8.01 | +74.78% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $14.69 | +1,398.13% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $3.00 | +183.33% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $0.81
Upside: +9,776.54%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400 → $300
Current: $7.46
Upside: +3,921.45%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.16
Upside: +3,576.47%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $0.96
Upside: +3,564.92%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $1.97
Upside: +204.57%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $3.83
Upside: +683.29%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $15.40
Upside: -35.06%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $17.35
Upside: +182.42%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $63,000 → $1,800
Current: $3.65
Upside: +49,215.07%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $6.03
Upside: +35,720.90%
Dec 7, 2021
Initiates: Buy
Price Target: $120
Current: $1.69
Upside: +7,000.59%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.59
Upside: +1,604.16%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $40.07
Upside: +39.76%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $4.90
Upside: +451.02%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $1.07
Upside: +3,171.03%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.34
Upside: +795.52%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $24.52
Upside: +205.87%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $2.18
Upside: +3,936.70%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $0.61
Upside: +29,471.22%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $11.30
Upside: +1,095.22%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $8.01
Upside: +74.78%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $14.69
Upside: +1,398.13%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $3.00
Upside: +183.33%